![Kenneth Hallock](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 6 M $ al 31/08/2026
Kenneth Hallock is currently an Independent Director at Greenwich LifeSciences, Inc., a position held since 2019.
Mr. Hallock completed undergraduate studies at Princeton University and earned an MBA from Harvard Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 26/05/2026 | 397.333 ( 2,71 % ) | 6 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GREENWICH LIFESCIENCES, INC. | Director/Miembro de la Junta | 01/09/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Greenwich LifeSciences, Inc.
 Greenwich LifeSciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapy to prevent breast cancer recurrences | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
